Page last updated: 2024-10-24

chlorambucil and Foot Diseases

chlorambucil has been researched along with Foot Diseases in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Foot Diseases: Anatomical and functional disorders affecting the foot.

Research Excerpts

ExcerptRelevanceReference
"Chlorambucil appears to be an effective and well tolerated prednisolone sparing agent for treatment of CEG."5.43Canine eosinophilic granuloma of the digits treated with prednisolone and chlorambucil. ( Knight, EC; Shipstone, MA, 2016)
"Chlorambucil appears to be an effective and well tolerated prednisolone sparing agent for treatment of CEG."1.43Canine eosinophilic granuloma of the digits treated with prednisolone and chlorambucil. ( Knight, EC; Shipstone, MA, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knight, EC1
Shipstone, MA1
Harnalikar, M1
Pande, S1
Kharkar, V1
Khopkar, U1

Other Studies

2 other studies available for chlorambucil and Foot Diseases

ArticleYear
Canine eosinophilic granuloma of the digits treated with prednisolone and chlorambucil.
    Veterinary dermatology, 2016, Volume: 27, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Dog Diseases; Do

2016
Keratotic vascular papules over the feet: a case of Waldenström's macroglobulinaemia-associated cutaneous macroglobulinosis.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:3

    Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Diagnosis, Differential; Fluorescent Antibody

2010